Compagnie Lombard Odier SCmA’s Rennova Health, Inc. RNVA Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio RNVA Stock Details RNVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-30	Closed	-$1K	–	888
2016 Q4	$1K	Hold	30	–	–	﹤0.01%	803
2016 Q3	$3K	Hold	30	–	–	﹤0.01%	884
2016 Q2	$9K	Buy	+30	New	+$9.04K	﹤0.01%	843

Other funds holding RNVA

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Compagnie Lombard Odier SCmA's RNVA Position: Q1 2017 in Review

Compagnie Lombard Odier SCmA sold out of Rennova Health, Inc. (RNVA) in Q1 2017, closing a stake of 30 shares — an estimated $1K sold.

Compagnie Lombard Odier SCmA first reported a position in RNVA in Q2 2016 and held it in 3 quarters. The position peaked at $9K in Q2 2016. 9 funds tracked by Wall St. Rank hold RNVA as of Q1 2017.

Compagnie Lombard Odier SCmA reported no remaining Rennova Health, Inc. position as of Q1 2017 after selling out during the quarter.
Compagnie Lombard Odier SCmA sold 30 Rennova Health, Inc. shares in Q1 2017, an estimated $1K.
Compagnie Lombard Odier SCmA first reported a position in Rennova Health, Inc. in Q2 2016 and held it in 3 quarters.
Compagnie Lombard Odier SCmA's Rennova Health, Inc. position peaked at $9K in Q2 2016.
9 funds tracked by Wall St. Rank held Rennova Health, Inc. as of Q1 2017.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2017, filed 15 May 2017.